Singapore markets closed

Viatris Inc. (VTRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.86+0.05 (+0.51%)
At close: 04:00PM EDT
10.00 +0.14 (+1.42%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close9.81
Bid9.84 x 2900
Ask10.00 x 4000
Day's range9.84 - 10.02
52-week range8.46 - 12.40
Avg. volume8,391,671
Market cap11.827B
Beta (5Y monthly)1.18
PE ratio (TTM)6.44
EPS (TTM)1.53
Earnings date06 Nov 2023 - 10 Nov 2023
Forward dividend & yield0.48 (4.89%)
Ex-dividend date23 Aug 2023
1y target est14.78
  • Zacks

    Viatris (VTRS) Gets FDA Nod for Pupil Dilation Reversal Agent

    Viatris (VTRS) and partner Ocuphire Pharma receive FDA approval for Ryzumvi to treat pharmacologically-induced mydriasis of the pupils.

  • Motley Fool

    Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks

    If you have a decent nest egg saved up, you can use it to invest in dividend stocks to improve your financial position. Three stocks that pay high yields and that could help accomplish this include Viatris (NASDAQ: VTRS), Verizon Communications (NYSE: VZ), and Altria Group (NYSE: MO). Generic and branded drugmaker Viatris has the potential to make for a stable long-term investment.

  • Motley Fool

    3 Pharmaceutical Stocks That Are Too Cheap to Ignore

    On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. Viatris (NASDAQ: VTRS), GSK (NYSE: GSK), and Organon (NYSE: OGN) are too inexpensive to pass up at this point. Let's look at some other reasons these three pharmaceutical stocks are too cheap to ignore.